Division of Nephrology, Department of Medicine, McGill University Health Centre Research Institute EM13238, 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1, Canada.
Nat Rev Nephrol. 2017 Nov;13(11):681-696. doi: 10.1038/nrneph.2017.129. Epub 2017 Oct 3.
Progress has been made in our understanding of the mechanisms of endoplasmic reticulum (ER) proteostasis, ER stress and the unfolded protein response (UPR), as well as ER stress-induced autophagy, in the kidney. Experimental models have revealed that disruption of the UPR, including a protein that senses misfolded proteins (namely, inositol-requiring enzyme 1α) in mouse podocytes causes podocyte injury and albuminuria as mice age. Protein misfolding and ER stress are evident in various renal diseases, including primary glomerulonephritides, glomerulopathies associated with genetic mutations, diabetic nephropathy, acute kidney injury, chronic kidney disease and renal fibrosis. The induction of ER stress may be cytoprotective, or it may be cytotoxic by activating apoptosis. The UPR may interact in a coordinated manner with autophagy to alleviate protein misfolding and its consequences. Monitoring the excretion of ER chaperones into the urine can potentially serve as a biomarker of renal ER stress. In specific kidney diseases, the treatment of experimental animals with chemical chaperones that improve protein folding or with chaperone inducers has alleviated kidney injury. Given the limited availability of mechanism-based therapies for kidney diseases, normalization of ER stress using pharmacological agents represents a promising therapeutic approach towards preventing or arresting the progression of kidney disease.
我们对内质网(ER)蛋白稳态、ER 应激和未折叠蛋白反应(UPR)的机制,以及 ER 应激诱导的自噬的理解已经取得了进展。实验模型表明,UPR 的破坏,包括一种感知错误折叠蛋白(即肌醇需求酶 1α)的蛋白质,会导致小鼠足细胞损伤和白蛋白尿随着年龄的增长。蛋白质错误折叠和 ER 应激在各种肾脏疾病中都很明显,包括原发性肾小球肾炎、与基因突变相关的肾小球病、糖尿病肾病、急性肾损伤、慢性肾脏病和肾纤维化。ER 应激的诱导可能具有细胞保护作用,也可能通过激活细胞凋亡而具有细胞毒性。UPR 可能通过与自噬协调作用来减轻蛋白质错误折叠及其后果。监测 ER 伴侣排入尿液中的情况可能潜在地作为肾脏 ER 应激的生物标志物。在特定的肾脏疾病中,用改善蛋白质折叠的化学伴侣物或伴侣物诱导物治疗实验动物,已经减轻了肾脏损伤。鉴于肾脏疾病的机制治疗方法有限,使用药理学药物使 ER 应激正常化代表了一种有前途的治疗方法,可以预防或阻止肾脏疾病的进展。